We can't find the internet
Attempting to reconnect
19085.1 PFLS-LS
Biosensors for patient self-monitoring in metabolic diseases
Zusammenfassung
Biosensors for patient self-monitoring in metabolic diseases
Weitere Texte
Abstract
Patients suffering from the metabolic disease Maple Syrup Urine Disease (MSUD) have to undergo regular blood tests in order to monitor their branched chain amino acid (Leu, Ile and Val) levels. Based on a conceptually new sensing mechanism, we will develop biosensors that will allow patients to do these tests themselves using a simple handheld device; similar to the way diabetics monitor their blood sugar levels.
Beteiligte
Alberto Schena
Wirtschaftspartner
alberto.schena@lucentix.ch
Lucentix Alberto Schena Bâtiment C / EPFL Innovation Park 1015 Lausanne VD CH
Kai Johnsson
Kontaktperson
kai.johnsson@epfl.ch
EPFL SB ISIC LIP Kai Johnsson Bâtiment BCH 4303 1015 Lausanne VD CH
Projektdetails
- Forschungsstelle
- INNOSUISSE
- Projektstatus
- Abgeschlossen
- Projekttyp
- Forschungsprojekt
- Startdatum
- 2016-06-30
- Enddatum
- 2017-07-31
- Bewilligte Gesamtkosten
- CHF 105252.00
- Sektion
- 20 Förderbereich Life Sciences
- NABS Politikbereich
- Industrielle Produktivität und Technologie
Forschungsdisziplinen
- T115 Medical technology 100.0%